These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 7862649)

  • 41. Developmental abnormalities in mice transgenic for bovine oncostatin M.
    Malik N; Haugen HS; Modrell B; Shoyab M; Clegg CH
    Mol Cell Biol; 1995 May; 15(5):2349-58. PubMed ID: 7739518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiotrophin-1 in cardiovascular regulation.
    Jougasaki M
    Adv Clin Chem; 2010; 52():41-76. PubMed ID: 21275339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pioglitazone inhibits cardiac hypertrophy of rats in vitro and in vivo].
    Ye P; Zhang C; Wu SM; Liu YX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Feb; 21(1):35-9. PubMed ID: 21166160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hematopathology of interleukin 6-type cytokines.
    Hawley RG
    Stem Cells; 1994; 12 Suppl 1():155-71. PubMed ID: 7696960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conditional gp130 deficient mouse mutants.
    Fasnacht N; Müller W
    Semin Cell Dev Biol; 2008 Aug; 19(4):379-84. PubMed ID: 18687405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-6 cytokine family member oncostatin M is a hair-follicle-expressed factor with hair growth inhibitory properties.
    Yu M; Kissling S; Freyschmidt-Paul P; Hoffmann R; Shapiro J; McElwee KJ
    Exp Dermatol; 2008 Jan; 17(1):12-9. PubMed ID: 17979974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
    Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation.
    Fredj S; Bescond J; Louault C; Delwail A; Lecron JC; Potreau D
    J Cell Physiol; 2005 Aug; 204(2):428-36. PubMed ID: 15717324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiotrophin-1: a novel cytokine and its effects in the heart and other tissues.
    Latchman DS
    Pharmacol Ther; 2000 Jan; 85(1):29-37. PubMed ID: 10674712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
    Bellido T; Stahl N; Farruggella TJ; Borba V; Yancopoulos GD; Manolagas SC
    J Clin Invest; 1996 Jan; 97(2):431-7. PubMed ID: 8567964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes.
    Nakaoka Y; Nishida K; Fujio Y; Izumi M; Terai K; Oshima Y; Sugiyama S; Matsuda S; Koyasu S; Yamauchi-Takihara K; Hirano T; Kawase I; Hirota H
    Circ Res; 2003 Aug; 93(3):221-9. PubMed ID: 12855672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiotrophin-1 in hypertensive heart disease.
    González A; López B; Ravassa S; Beaumont J; Zudaire A; Gallego I; Brugnolaro C; Díez J
    Endocrine; 2012 Aug; 42(1):9-17. PubMed ID: 22418690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The zinc finger-only protein Zfp260 is a novel cardiac regulator and a nuclear effector of alpha1-adrenergic signaling.
    Debrus S; Rahbani L; Marttila M; Delorme B; Paradis P; Nemer M
    Mol Cell Biol; 2005 Oct; 25(19):8669-82. PubMed ID: 16166646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
    Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct injection and expression in vivo of full-length cDNA of the cardiac isoform of alpha-2 macroglobulin induces cardiac hypertrophy in the rat heart.
    Rajan S; Radhakrishnan J; Rajamanickam C
    Basic Res Cardiol; 2003 Feb; 98(1):39-49. PubMed ID: 12494268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent.
    Latchman DS
    Int J Exp Pathol; 1999 Aug; 80(4):189-96. PubMed ID: 10583628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiotrophin-1. Review.
    Stejskal D; Ruzicka V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):9-19. PubMed ID: 18795069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Size matters: Finding growth pathways that protect the heart.
    Guseh JS; Rosenzweig A
    Cell Res; 2017 Oct; 27(10):1187-1188. PubMed ID: 28925384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of cardiotrophin-1 in obesity and insulin resistance.
    Moreno-Aliaga MJ; Romero-Lozano MA; Castaño D; Prieto J; Bustos M
    Adipocyte; 2012 Apr; 1(2):112-115. PubMed ID: 23700521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pathogenesis of cardiac hypertrophy.
    NORMAN TD
    Prog Cardiovasc Dis; 1962 Mar; 4():439-63. PubMed ID: 14480358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.